selected publications
- Current landscape of CD3 bispecific antibodies in hematologic malignancies. Trends in cancer. 2024 Review GET IT
- Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma. Blood advances. 2024 Academic Article GET IT
- Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma. Blood advances. 2023 Academic Article GET IT
- Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation. 2023 Letter GET IT
- Long Covid in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection. American journal of clinical oncology. 2023 Academic Article GET IT
- Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies. Frontiers in cell and developmental biology. 2022 Review GET IT
- Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?. Clinical advances in hematology & oncology : H&O. 2021 Information Resource GET IT
-
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Academic Article
GET IT
Times cited: 109 - An update on options of therapy for aggressive mantle cell lymphoma. Leukemia & lymphoma. 2020 Review GET IT
-
IMiDs New and Old.
Current hematologic malignancy reports.
2019
Information Resource
GET IT
Times cited: 14 -
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis.
Blood advances.
2018
Review
GET IT
Times cited: 10